| scholarly article | Q13442814 |
| P50 | author | Joel K Joelsson | Q83893150 |
| Emma Bergfelt Lennmyr | Q89813855 | ||
| Piotr Kozlowski | Q57305538 | ||
| P2093 | author name string | Anna Lübking | |
| Beata Tomaszewska-Toporska | |||
| Karin Karlsson | |||
| Lucia Ahlberg | |||
| Erik Hulegårdh | |||
| Helene Hallböök | |||
| Andreea Moicean | |||
| Hege Garelius | |||
| Antonio S Izarra | |||
| Swedish Adult Acute Lymphoblastic Leukaemia Group (SVALL) | |||
| P2860 | cites work | Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute | Q58545119 |
| Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience | Q64048474 | ||
| Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogénétique Hématologique | Q71010507 | ||
| Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia | Q73399572 | ||
| Prognostic factors in elderly acute lymphoblastic leukaemia | Q73476169 | ||
| Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience | Q77785530 | ||
| Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche de | Q79527735 | ||
| Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival | Q81573779 | ||
| A population-based cytogenetic study of adults with acute lymphoblastic leukemia | Q84865592 | ||
| Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology | Q87120157 | ||
| High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden | Q87130047 | ||
| Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial | Q88973604 | ||
| New drugs in AML: uses and abuses | Q89014470 | ||
| Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry | Q33384383 | ||
| Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial | Q34737471 | ||
| Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia | Q35146312 | ||
| Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia. | Q35178966 | ||
| Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia | Q35542516 | ||
| Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia | Q35602915 | ||
| Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. | Q35651744 | ||
| High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007. | Q36216252 | ||
| Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study | Q36478476 | ||
| Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts | Q37273171 | ||
| Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL | Q37376595 | ||
| Survival of adults with acute lymphoblastic leukemia in Germany and the United States | Q37520582 | ||
| Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence | Q37558947 | ||
| Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia | Q39315839 | ||
| How I treat older patients with ALL. | Q39419031 | ||
| Sex and prognosis in childhood acute lymphoblastic leukaemia | Q39493952 | ||
| Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden. | Q40238184 | ||
| Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients | Q40671094 | ||
| Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia | Q40731204 | ||
| Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival | Q41472241 | ||
| Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998-2008. | Q43833498 | ||
| High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia | Q44103817 | ||
| Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. | Q46174384 | ||
| Population-based analyses in adult acute lymphoblastic leukemia | Q46339490 | ||
| The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis | Q46562404 | ||
| Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database | Q48154770 | ||
| Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia. | Q50501063 | ||
| Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. | Q50970578 | ||
| Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia. | Q51509066 | ||
| Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of th | Q52572829 | ||
| Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. | Q52975939 | ||
| Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia. | Q53544852 | ||
| Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia. | Q53825078 | ||
| Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients | Q57048029 | ||
| Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) | Q58414406 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 88-98 | |
| P577 | publication date | 2019-06-06 | |
| P1433 | published in | European Journal of Haematology | Q15765799 |
| P1476 | title | Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry | |
| P478 | volume | 103 |
Search more.